Anavex Life Sciences Management
Management criteria checks 3/4
Anavex Life Sciences' CEO is Chris Missling, appointed in Jul 2013, has a tenure of 11.33 years. total yearly compensation is $3.89M, comprised of 18% salary and 82% bonuses, including company stock and options. directly owns 1.47% of the company’s shares, worth €10.94M. The average tenure of the management team and the board of directors is 2.8 years and 10.5 years respectively.
Key information
Chris Missling
Chief executive officer
US$3.9m
Total compensation
CEO salary percentage | 18.0% |
CEO tenure | 11.3yrs |
CEO ownership | 1.5% |
Management average tenure | 2.8yrs |
Board average tenure | 10.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$42m |
Mar 31 2024 | n/a | n/a | -US$41m |
Dec 31 2023 | n/a | n/a | -US$43m |
Sep 30 2023 | US$4m | US$700k | -US$48m |
Jun 30 2023 | n/a | n/a | -US$52m |
Mar 31 2023 | n/a | n/a | -US$53m |
Dec 31 2022 | n/a | n/a | -US$50m |
Sep 30 2022 | US$7m | US$586k | -US$48m |
Jun 30 2022 | n/a | n/a | -US$45m |
Mar 31 2022 | n/a | n/a | -US$43m |
Dec 31 2021 | n/a | n/a | -US$41m |
Sep 30 2021 | US$9m | US$550k | -US$38m |
Jun 30 2021 | n/a | n/a | -US$32m |
Mar 31 2021 | n/a | n/a | -US$28m |
Dec 31 2020 | n/a | n/a | -US$28m |
Sep 30 2020 | US$2m | US$550k | -US$26m |
Jun 30 2020 | n/a | n/a | -US$26m |
Mar 31 2020 | n/a | n/a | -US$26m |
Dec 31 2019 | n/a | n/a | -US$26m |
Sep 30 2019 | US$3m | US$513k | -US$26m |
Jun 30 2019 | n/a | n/a | -US$26m |
Mar 31 2019 | n/a | n/a | -US$23m |
Dec 31 2018 | n/a | n/a | -US$20m |
Sep 30 2018 | US$3m | US$500k | -US$17m |
Compensation vs Market: Chris's total compensation ($USD3.89M) is above average for companies of similar size in the German market ($USD1.46M).
Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.
CEO
Chris Missling (58 yo)
11.3yrs
Tenure
US$3,894,453
Compensation
Dr. Christopher U. Missling, also known as the Chris, MS, Ph D., MBA, has been the Chief Executive Officer and President at Anavex Life Sciences Corp. since July 05, 2013 and also serves as its Director an...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 11.3yrs | US$3.89m | 1.47% € 10.9m | |
Principal Financial Officer & Treasurer | 9.1yrs | US$501.06k | 0.027% € 200.9k | |
Chief Scientific Officer | 2.8yrs | no data | no data | |
VP of Corporate | no data | no data | no data | |
Senior Vice President of Nonclinical Development | 3.5yrs | no data | no data | |
Chief Medical Officer | 2.8yrs | no data | no data | |
Head of Biostatistics | 1.7yrs | no data | no data | |
Senior Vice President of Regulatory Affairs | less than a year | no data | no data | |
Senior Vice President of Clinical Development | less than a year | no data | no data | |
Senior VP & Head of Research and Development | less than a year | no data | no data |
2.8yrs
Average Tenure
Experienced Management: 12X1's management team is considered experienced (2.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 11.3yrs | US$3.89m | 1.47% € 10.9m | |
Independent Chairman | 3.5yrs | US$349.54k | no data | |
Member of the Scientific Advisory Board | 9.7yrs | no data | no data | |
Member of the Scientific Advisory Board | 13.8yrs | no data | no data | |
Member of the Scientific Advisory Board | 10.9yrs | no data | no data | |
Member of the Scientific Advisory Board | 11yrs | no data | no data | |
Member of the Scientific Advisory Board | no data | no data | no data | |
Independent Director | 11.8yrs | US$341.54k | 1.54% € 11.4m | |
Member of the Scientific Advisory Board | 10.5yrs | no data | no data | |
Member of the Scientific Advisory Board | 9.7yrs | no data | no data | |
Independent Director | 9.4yrs | US$341.54k | 0.0059% € 43.8k | |
Lead Independent Director | 6.7yrs | US$357.54k | no data |
10.5yrs
Average Tenure
58yo
Average Age
Experienced Board: 12X1's board of directors are seasoned and experienced ( 10.5 years average tenure).